Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

Abstract Lewy body dementia (LBD) is a neurodegenerative disorder characterized by a combination of progressive dementia and spontaneous parkinsonian symptoms. As the second most prevalent form of neurodegenerative dementia after Alzheimer’s disease (AD), LBD necessitates a deeper understanding of i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingfeng Liang, Rongzhen Li, Garry Wong, Xiaobing Huang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Molecular Neurodegeneration
Subjects:
Lewy body dementia
Dementia with Lewy bodies
Parkinson’s disease dementia
Amyloid β
Tau
Α-synuclein
Online Access:https://doi.org/10.1186/s13024-025-00879-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items